azauracil has been researched along with ce 224,535 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaulieu, AM; Chang, SP; Dombroski, MA; Duplantier, AJ; Gabel, CA; Jordan, C; Kalgutkar, AS; Kraus, KG; Labasi, JM; Mussari, C; Perregaux, DG; Shepard, R; Subramanyam, C; Taylor, TJ; Trevena, KA; Whitney-Pickett, C; Yoon, K | 1 |
1 other study(ies) available for azauracil and ce 224,535
Article | Year |
---|---|
Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.
Topics: Administration, Oral; Animals; Antirheumatic Agents; Benzamides; Drug Discovery; Humans; Inhibitory Concentration 50; Molecular Structure; Protein Binding; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Structure-Activity Relationship; Uracil | 2011 |